KM, L., Z, M., N, A., AE, E., & RH, S. (2026). The protective effect of febuxostat in a rotenone mouse model of Parkinson's disease: The interplay between PI3K/Akt/mTOR, GSK-3β, and Nrf2/HO-1 signaling pathways. The Journal of pharmacy and pharmacology, 78(2), . https://doi.org/10.1093/jpp/rgag009
Chicago Style (17th ed.) CitationKM, Lasheen, Mohammad Z, Ahmed N, El-Sahar AE, and Sayed RH. "The Protective Effect of Febuxostat in a Rotenone Mouse Model of Parkinson's Disease: The Interplay Between PI3K/Akt/mTOR, GSK-3β, and Nrf2/HO-1 Signaling Pathways." The Journal of Pharmacy and Pharmacology 78, no. 2 (2026). https://doi.org/10.1093/jpp/rgag009.
MLA (9th ed.) CitationKM, Lasheen, et al. "The Protective Effect of Febuxostat in a Rotenone Mouse Model of Parkinson's Disease: The Interplay Between PI3K/Akt/mTOR, GSK-3β, and Nrf2/HO-1 Signaling Pathways." The Journal of Pharmacy and Pharmacology, vol. 78, no. 2, 2026, https://doi.org/10.1093/jpp/rgag009.
